These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient. Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198 [TBL] [Abstract][Full Text] [Related]
9. Erythrodermic pityriasis rubra pilaris managed at home: intensive community care followed by ustekinumab. Ismail N; Callander J; Williams M; Anstey AV Clin Exp Dermatol; 2018 Aug; 43(6):749-751. PubMed ID: 29779249 [No Abstract] [Full Text] [Related]
10. Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris. Dessinioti C; Vergou T; Moustou E; Katsambas A; Antoniou C Eur J Dermatol; 2011; 21(4):599-600. PubMed ID: 21518691 [No Abstract] [Full Text] [Related]